
Startup | Founder of Zemlin Healthcare Pvt Ltd - Trusted Health Partner
Startup Stage : Validation Stage
Office No 122 JG Block Vardhman Market Vikaspuri Outer Ring Road , New Delhi, Delhi, India - 110018
India’s pharmaceutical market faces a gap between affordability and consistent quality. Zemlin Healthcare addresses this by delivering high-quality, affordable medicines while building a scalable brand portfolio. With a focus on expanding branded formulations, strengthening marketing, and launching future patented products, Zemlin aims to establish a strong pan-India presence.
Startups thrive by identifying real-world challenges and solving them with innovation. This section highlights the specific problem they address and the practical solution they’ve crafted to create meaningful impact and lasting value.
A large segment of patients and healthcare providers in India struggle with accessing high-quality medicines at affordable prices. The market is fragmented, with inconsistent quality standards, high costs of branded drugs, and limited reach of reliable pharmaceutical brands in Tier 2 and Tier 3 markets.
Zemlin Healthcare addresses this gap by offering high-quality, affordable pharmaceutical products while building a strong branded portfolio. Through focused distribution, strategic marketing, and expansion into new geographies, the company aims to improve accessibility. Future plans include launching patented products to strengthen differentiation and long-term market positioning.
In Delhi NCR 52 plus corporate hospitals , 400 plus Secondary care hospitals and 1100 plus nursing homes. If our our single brand is approved in each hospital then we will do minimum 2 cr plus sales in Delhi NCR only.
Every startup needs a clear direction. This section showcases their vision for the future and the roadmap that connects today’s actions with tomorrow’s goals — from near-term milestones to long-term impact.
Expand product portfolio and strengthen distribution across key regional markets
Achieve strong brand presence and increase sales through focused marketing strategies
Introduce patented products and strengthen positioning in specialized therapeutic segments
Establish pan-India presence with a diversified and scalable pharmaceutical portfolio
Every startup is powered by its people. This section introduces the team — founders, innovators, and professionals who bring diverse skills, creativity, and dedication to drive the vision forward and build solutions that create lasting impact.





Pictures tell stories beyond words. This section captures moments that define the startup — team culture, events, product showcases, and milestones — offering a glimpse into their spirit, passion, and journey.
Startups grow with the right support. This section highlights their ask from the community — funding, mentorship, partnerships, customers, or collaborations — making needs clear and inviting the right opportunities to fuel growth.
Seeking ₹30 lakh investment to expand product portfolio and strengthen distribution.
Numbers speak louder than words. This section highlights the key business metrics — traction, revenue, users, customers, and milestones — showcasing real progress, validating the solution, and reflecting measurable impact in the market.
4.5 Lakhs Approx
35%
3 Lakhs
Not Fix
No Limit
15
Zero
Zero
In between 10 to 30 %.
0
245%
Less than 1%
Trust begins with compliance. This section answers key FAQs on legal and regulatory practices — from registration and licenses to filings and governance — ensuring startups build credibility, transparency, and sustainable growth with investors, customers, and partners.
2023-11-22
07AACCZ3079M1ZR
2024-10-17
Drug License - 20 B - WLF20B2024DL002142
Yes
Yes Director 1 - 10276659 Director 2 - 10276675
Drug License 21 B - WLF21B2024DL002117
Rented Office
Yes
2024-2025
No
No
Approved
No
Yes
This section brings together the startup’s key documents — pitch deck, company profile, and product/service catalogue — ready to download and explore for a complete understanding of their vision, story, and offerings.